Rasula, Leonora A.
HRN: 28-49-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2026
CEFTRIAXONE 1G (VIAL)
02/05/2026
02/12/2026
IV
2g
OD
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: